About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

LOG IN
LOG IN


76 Food & Drug L.J. [i] (2021)

handle is hein.journals/foodlj76 and id is 1 raw text is: Food and Drug Law Journal (ISSN: 1064-590X) Published quarterly by the Food and Drug Law Institute, 1155 15th St., N.W., Suite 910, Washington, D.C. 20005-2706, www.fdli.org. The Food and Drug Law Journal is devoted to the analysis of legislation, regulations, court decisions, and public policies affecting industries regulated by the U.S. Food and Drug Administration (FDA) and related agencies and authorities, including the development, manufacture, marketing, and use of drugs, medical devices, biologics, food, dietary supplements, cosmetics, veterinary, tobacco, and cannabis-derived products. Following the mission of FDLI to promote an understanding of this field of law and regulation, the Journal provides a neutral forum for scholarly debate and exchange of views in accordance with the highest professional standards. Statements of fact and opinion are the sole responsibility of the authors. Neither the Journal nor FDLI advocates a particular opinion on issues addressed. 2021: Volume 76 Member Price: $299.00 Nonmember Price: $379.00. DC orders include 5.75% sales tax. Complimentary postage and handling for domestic orders. Postage and handling additional for international subscribers. Periodicals postage paid at Washington, DC and additional mailing offices. Information and queries about subscriptions should be directed to info@fdli.org. Information about submissions: Editor in Chief, publications fdli.org. POSTMASTER: Send changes of address to the Food and Drug Law Journal, c/o Customer Service Department, The Food and Drug Law Institute, 1155 15th St., N.W., Suite 910, Washington, DC 20005-2706. Articles indexed in the Journal are available through HemOnline and also are listed in the Current Contents indexes and the Excerpta Medica database EMBASE. Selected articles may be retrieved on WESTLAW and LEXIS. © Copyright 2021 by The Food and Drug Law Institute.